Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management. - Wikidata - thesis-toulmin - TriplyDB

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

http://www.wikidata.org/entity/Q30249553

about

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases Psychosis in parkinsonism: an unorthodox approach.Genetic loci associated with an earlier age at onset in multiplex schizophrenia.ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.Association between Parkinson's disease and risk of prostate cancer in different populations: An updated meta-analysis.Insights into Pathophysiology from Medication-induced Tremor.Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.Parkinson's disease psychosis: presentation, diagnosis and management.Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.Management of common adverse effects of antipsychotic medications

P2860

Q28066691-731BAB4A-B63A-48A4-91DD-F25E6B0B5A17 Q39335522-63A3FBD9-73EB-47D4-8964-0505777FDA49 Q40108507-8D992D08-138A-44E2-A6AF-2675ED5FAF48 Q41824342-83A0C3A0-F090-4257-A1B7-5E79C0FAD3BA Q42677271-24E793EB-CB80-4C46-860D-7BAB7D78879F Q47128750-B4CF87D9-4603-4EC8-907B-7891D19775BC Q47794742-9930B7B9-F629-4AAF-A71F-FAADA3ECE05B Q48300577-A9B0C035-9D88-43D6-8ED9-704A7F296C72 Q48492369-474202F4-D97F-42EB-A4B7-C3B39AC67B71 Q51781286-60B86050-EA5C-4A6D-B83D-3D6ED7976EBB Q52677977-608A7EC9-1051-430B-8C56-7609B8EF391E Q58760350-783EDB8B-5E60-4637-BA59-3971062A63AC

P2860

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

http://www.wikidata.org/entity/Q30249553

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@ast

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@en

type

label

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@ast

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@en

prefLabel

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@ast

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@en

P1433

Q30249553-2584AA27-AA9A-4C23-808D-453FE9CDAB6A

P1476

Q30249553-A2BF3938-3D52-48A2-B197-11EAAFBF3748

P2093

Q30249553-CAF2E431-9235-4297-BE87-FE5C3E9C9F19

P2860

Q30249553-015A0909-0686-4375-AB8E-72F329FD904B

Q30249553-018A3A8F-059F-43D4-9295-1340545D8B7F

Q30249553-02927AC7-1084-44A8-8150-9008D1AEF249

Q30249553-0399CF34-269B-453C-AFBB-E0E060B37F18

Q30249553-04D54686-3201-4C88-BB51-30AA6BAEF34D

Q30249553-0559B698-1DD5-4E25-8443-F910D4D4311B

Q30249553-056B743A-D1C1-47E1-9494-64151780BA4E

Q30249553-05816ADB-0232-4DC2-8BE1-9D1C4F622E4C

Q30249553-05C2C972-F088-449C-AD21-83F4C078E438

Q30249553-0712BBDD-C598-466D-B773-406EF338953F

P2888

Q30249553-36FF6685-42CC-4C72-8DC5-6245AFE2E81A

P304

Q30249553-675B5CF2-FD18-460A-86C0-5933601E89E3

P31

Q30249553-C59067B8-F2EC-45C4-BCFD-F3B53F131C46

P356

Q30249553-E3EE3F17-A395-4744-BDEC-2DA3F53FA51A

P433

Q30249553-E0DD33F5-8394-455B-B055-F1793D1B3766

P478

Q30249553-3E29EA8F-6093-436C-AE7E-674CE4E54A7C

P50

Q30249553-33CDF925-CBAF-4F9D-9FAA-85E2F7BE19D9

P577

Q30249553-1C726467-2239-4901-98B0-AB58624F7D9F

P6179

Q30249553-A7334F5C-05DA-4206-93A6-F8B0886F07EB

P698

Q30249553-987960A1-CE33-4C9A-A9D6-42960517041E

P921

Q30249553-4C936FCB-EAB3-4E11-893D-E1DF708C73CB

Q30249553-D066E418-FD51-47CB-A346-813821955E0F

Q30249553-D368D1A1-69CC-467F-8D5A-200D279B2C47

P356

S40265-016-0600-5

P1433

P1476

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

@en

P2093

Anna Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis

Parkinson disease psychosis: Update

Separate visual pathways for perception and action

Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease

Dopamine receptors - IUPHAR Review 13

Melperone is ineffective in treating Parkinson's disease psychosis

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

P2888

s40265-016-0600-5

P304

1093-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0600-5

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021255013

http://www.w3.org/2001/XMLSchema#string

P698

27312429

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

pathophysiology